Projects per year
Fingerprint Dive into the research topics where Raymond Bergan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Genistein
Medicine & Life Sciences
Prostate
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Cell Movement
Medicine & Life Sciences
Oligodeoxyribonucleotides
Medicine & Life Sciences
Suramin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1977 2020
Cell Movement
Neoplasm Metastasis
Prostatic Neoplasms
Phosphorylation
Neoplasms
SPORE in Prostate Cancer
Bergan, R., Jindan, Y., Kaul, K. L., Catalona, W., Jovanovic, B., Abdulkadir, S. A. & Szmulewitz, R.
8/18/15 → 7/31/20
Project: Research project
Research Personnel
Prostatic Neoplasms
Mentors
Research
Publications
Genistein-mediated Regulation of Prostate Cancer Cell Motility
9/23/08 → 7/31/14
Project: Research project
Genistein
Cell Movement
Prostatic Neoplasms
HSP27 Heat-Shock Proteins
Prostate
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
Bergan, R. & Bergan, R.
9/30/03 → 9/29/12
Project: Research project
Prostate
Genistein
Prostatic Neoplasms
Cell Survival
Growth
Research Output 1991 2019
Genistein treatment duration effects biomarkers of cell motility in human prostate
Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 1 2019, In : PloS one. 14, 3, e0214078.Research output: Contribution to journal › Article
Open Access
Genistein
genistein
Biomarkers
cell movement
Cell Movement
Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Jan 1 2019, In : Nutrition and Cancer.Research output: Contribution to journal › Article
Phosphatidylinositol 3-Kinases
Drug Resistance
Doxorubicin
Cell Line
HL-60 Cells
Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors
Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Jan 1 2019, In : ChemMedChem.Research output: Contribution to journal › Article
MAP Kinase Kinase 4
Benzoic Acid
Molecular modeling
Oncology
p38 Mitogen-Activated Protein Kinases
Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity
Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.Research output: Contribution to journal › Article
Whole Body Imaging
Drug-Related Side Effects and Adverse Reactions
Cell Death
Drug Therapy
Toxicology
2
Citations
(Scopus)
DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer
Lu, E., Thomas, G., Chen, Y., Wyatt, A. W., Lloyd, P., Youngren, J., Quigley, D., Bergan, R., Bailey, S., Beer, T. T., Feng, F. Y., Small, E. J. & Alumkal, J., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 933-937 5 p.Research output: Contribution to journal › Article
Castration
DNA Repair
Prostatic Neoplasms
Genes
BRCA2 Gene